Difficulty: Medium
Average Score: 85%
Practice
Which of the following antianginal agents is the specific bradycardic drug:
Correct answer
D
Rationale
In the context of advanced pharmacology across the lifespan, understanding the specific actions of antianginal agents is crucial for safe and effective patient care. In this question, the correct answer is D) Alinidine because it is a specific bradycardic drug that acts by reducing heart rate, making it beneficial for patients with angina by decreasing myocardial oxygen demand.
Option A) Dipyridamole is a vasodilator and antiplatelet agent used in the prevention of thromboembolic events, not specifically for bradycardia. Option B) Validol, also known as menthol, is a mild coronary vasodilator and has a calming effect but is not a bradycardic drug. Option C) Atenolol is a beta-blocker commonly used in angina but does not have as specific a bradycardic effect as Alinidine.
Educationally, knowing the specific mechanisms of action of antianginal agents helps healthcare providers tailor treatment plans to individual patient needs. Understanding the distinctions between these drugs ensures safe prescribing practices and optimal patient outcomes.
Option A) Dipyridamole is a vasodilator and antiplatelet agent used in the prevention of thromboembolic events, not specifically for bradycardia. Option B) Validol, also known as menthol, is a mild coronary vasodilator and has a calming effect but is not a bradycardic drug. Option C) Atenolol is a beta-blocker commonly used in angina but does not have as specific a bradycardic effect as Alinidine.
Educationally, knowing the specific mechanisms of action of antianginal agents helps healthcare providers tailor treatment plans to individual patient needs. Understanding the distinctions between these drugs ensures safe prescribing practices and optimal patient outcomes.